Fast Facts: Biosimilars
Biosimilars have been in clinical use for more than 10 years, and evidence from more than 700 million patient-days' exposure shows that approved biosimilars can be used as safely and effectively as their originator biologics. And yet concerns about these drugs persist, particularly in therapy a...
Tallennettuna:
| Päätekijät: | Cornes, Paul, Bennett, David J. (Tekijä) |
|---|---|
| Aineistotyyppi: | Livre numérique |
| Kieli: | Anglais |
| Julkaistu: |
Basel :
S. Karger
2018.
Basel : |
| Linkit: | https://www.karger.com/Book/Home/277615 Accès Université d'Orléans et IFPM |
| Huomautus: |
Karger Fast Facts |
| Autres localisations: | Voir dans le Sudoc |
Samankaltaisia teoksia
-
Fast Facts: Biosimilares : Biológicos y biosimilares - ¿son lo suficientemente similares?
(Livre numérique)
Cornes, Paul, et al.
S. Karger, 2019 -
Fast Facts: Biosimilars in Hematology and Oncology : Biologics and biosimilars - getting decisions right
(Livre numérique)
Cornes, Paul, et al.
S. Karger, 2020 -
Fast Facts: Biosimilars /
(Livre numérique)
S. Karger, 2024 -
Biosimilars
(Livre numérique)
IntechOpen, 2022 -
Biosimilars in Europe
(Livre numérique)
MDPI - Multidisciplinary Digital Publishing Institute, 2023

